## What's Driving Mirum Pharmaceuticals' Strong Market Momentum?
**Mirum Pharmaceuticals** [MIRM](/market-activity/stocks/mirm) stock jumped 7.1% last week following the company's announcement of solid preliminary financial results and an ambitious development roadmap that captured investor attention. The pharmaceutical firm's strategic expansion in rare liver disease treatment appears to be resonating with the market, particularly as it broadens its therapeutic portfolio.
## Breaking Down the Numbers: 2025 Performance
The company delivered full-year 2025 net product sales reaching approximate